Ad is loading...
MENU
AXSM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Axsome Therapeutics (AXSM) Ownership - Who owns Axsome Therapeutics?

Profile

Industry
Pharmaceuticals Other
Address
One World Trade Center
Phone
+1 212 332-3241
Employees
545
Web
https://www.axsome.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.52B
P/E Ratio
N/A
Total Cash
315.66M
Projected Growth
N/A
Total Debt
191.8M
Revenue
291.49M
Risk (Beta)
0.68
Dividend Yield
N/A
Total Cash/Share
6.51
Total Debt/Equity
N/A
Revenue/Share
7.11 USD as % of share price

Fundamentals

AXSM
Capitalization
4.52B
P/E Ratio
N/A
Risk (Beta)
0.68
Dividend Yield
N/A
Total Cash
316M
Total Cash/Share
6.51
Total Debt
192M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
7.11%
Revenue
291M
ROE
N/A
Book Value
103M
P/B Ratio
48.54
Cash Flow
N/A
Earnings
-6.58
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
2.48
Current Revenue Per Employee
147989.81
Dividends Per Share - Security
N/A
EBITDA
-298.41M
Float
N/A
Float - Current
N/A
Gross Income Margin
90.76
Revenue To Assets
-53.20
Shares Held By Institutions
5.69B
Shares Outstanding - Current
48.5M
Total Liabilities
445M
Total Volume MTD
N/A
Value
-1
Gain YTD
17.062
View a ticker or compare two or three
AXSM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of biopharmaceutical services for pain and other nervous system

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
One World Trade Center
Phone
+1 212 332-3241
Employees
545
Web
https://www.axsome.com